1.22
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.26
Aprire:
$1.24
Volume 24 ore:
133.40K
Relative Volume:
0.58
Capitalizzazione di mercato:
$48.32M
Reddito:
$41.21M
Utile/perdita netta:
$-15.12M
Rapporto P/E:
-3.3898
EPS:
-0.3599
Flusso di cassa netto:
$-17.19M
1 W Prestazione:
-6.15%
1M Prestazione:
-25.61%
6M Prestazione:
+48.91%
1 anno Prestazione:
+11.93%
Myomo Inc Stock (MYO) Company Profile
Nome
Myomo Inc
Settore
Industria
Telefono
617-996-9058
Indirizzo
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MYO
Myomo Inc
|
1.22 | 48.32M | 41.21M | -15.12M | -17.19M | -0.3599 |
|
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-31 | Iniziato | Craig Hallum | Buy |
| 2024-05-20 | Iniziato | Lake Street | Buy |
| 2023-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2020-05-27 | Iniziato | Dougherty & Company | Buy |
| 2017-10-02 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Myomo Inc Borsa (MYO) Ultime notizie
Myomo, Inc. (MYO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Myomo CMO Harry Kovelman sells $20,136 in company stock By Investing.com - Investing.com South Africa
Myomo CMO Harry Kovelman sells $20,136 in company stock - Investing.com
Form 4 Myomo Inc: Harry Kovelman (Chief Medical Officer) For: 11 September - Investing.com Nigeria
Form 4 Myomo Inc: Harry Kovelman (Chief Medical Officer) For: 11 September - Investing.com UK
Myomo CMO Harry Kovelman sells $20,136 in company stock By Investing.com - Investing.com Nigeria
Form 4 Myomo Inc: David A. Henry (CFO) For: 13 October - Investing.com Nigeria
Form 4 Myomo Inc: Paul R. Gudonis (Director, CEO) For: 13 October By Investing.com - Investing.com South Africa
Myomo CEO Paul R. Gudonis Awarded 71,250 RSUs on October 13, 2026 - Kalkine Media
Form 4 Myomo Inc: Paul R. Gudonis (Director, CEO) For: 9 October - Investing.com Nigeria
Form 4 Myomo Inc: David A. Henry (CFO) For: 9 October - Investing.com Nigeria
Form 4 Myomo Inc: David A. Henry (CFO) For: 9 October - Investing.com Canada
To pay taxes only, Myomo (MYO) officer plans to sell 3,133 shares as stock grants vest. - Stock Titan
Form 4 Myomo Inc: Mary-Katherine Hale McClure (Chief Commericial Officer) For: 12 October - Investing.com India
Myomo appoints Mary-Katherine McClure as chief commercial officer - Investing.com
Myomo Names Mary-Katherine McClure as Chief Commercial Officer - Yahoo Finance
Myomo names new chief commercial officer effective October 2026 - StreetInsider
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer - Yahoo Finance
Q1 2025 Myomo Inc Earnings Call Transcript - GuruFocus
Q3 2025 Myomo Inc Earnings Call Transcript - GuruFocus
Myomo Inc (HAM:0M61) DCF Valuation - GuruFocus
Myomo Inc (HAM:0M61) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Myomo Inc Stock Operating Data - GuruFocus
Myomo Inc (HAM:0M61) Stock Price, Trades & News - GuruFocus
Spotlight On 3 Penny Stocks With Market Caps As Low As $10M - Simply Wall Street
Tangible book value per share of Myomo, Inc. – HAN:0M61 - TradingView
Discontinued operations of Myomo, Inc. – HAN:0M61 - TradingView
Preferred dividends of Myomo, Inc. – HAN:0M61 - TradingView
0M61 Forecast — Price Target — Prediction for 2027 - TradingView
Myomo Q2 2026 Earnings Call Transcript - Benzinga
ETFs Investing in Myomo, Inc. Stocks - TradingView
Myomo Inc (MYO) Chief Medical Officer Harry Kovelman Sells 15,48 - GuruFocus
Myomo (NYSE: MYO) insider to sell 15,844 shares after two recent sales - Stock Titan
Director of Myomo (NYSE: MYO) moves to sell shares from recent stock awards - Stock Titan
Myomo Inc. (MYO) Slips 0.7% to $1.42 as Shares Consolidate Within Narrow Trading RangeFactor Valuation - vinanet.vn
MYO Q2 2026 Earnings: EPS Miss of 18.81% Sends Shares Down 4.9%Earnings Decline Risk - vinanet.vn
Myomo Inc. (MYO) Slips 0.7% to $1.42 as Shares Consolidate Within Narrow Trading RangeZero Lag EMA - dars.gov.et
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - BioSpace
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Ascendiant Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $10.5 - Moomoo
Myomo CMO Harry Kovelman sells $30,329 in stock By Investing.com - Investing.com Nigeria
Myomo CMO Harry Kovelman sells $30,329 in stock By Investing.com - Investing.com India
Myomo CMO Harry Kovelman sells $30,329 in stock - Investing.com
Myomo (MYO) Latest: Moves 0.57% Lower to $1.73 on the Day; Technical View - vinanet.vn
Myomo (MYO) Q2 2026 Results: Profit Per Share Falls Below Its Benchmark for This Review; Market Reaction: The Stock Loses 0.57% for the Current SessionGross Profit Margin - vinanet.vn
Myomo (MYO) Q2 2026 Results: Profit Per Share Falls Below Its Benchmark for This Review; Market Reaction: The Stock Loses 0.57% for the Current SessionEarnings Yield Analysis - dars.gov.et
Myomo chief medical officer sells $29,895 in shares - Investing.com India
Insider Selling: Myomo (NYSEAMERICAN:MYO) Insider Sells 17,250 Shares of Stock - MarketBeat
Myomo chief medical officer sells $29,895 in shares - Investing.com
Myomo Inc Azioni (MYO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Myomo Inc Azioni (MYO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HARRY KOVELMAN | Officer |
Sep 11 '26 |
Proposed Sale |
1.27 |
15,844 |
20,136 |
0 |
| Kovelman Harry | Chief Medical Officer |
Sep 11 '26 |
Sale |
1.27 |
15,488 |
19,684 |
90,245 |
| Morris Milton Mayo | Director |
Sep 02 '26 |
Proposed Sale |
1.41 |
15,000 |
21,150 |
0 |
| Morris Milton Mayo | Director |
Sep 02 '26 |
Sale |
1.41 |
15,000 |
21,150 |
208,391 |
| Kovelman Harry | Chief Medical Officer |
Aug 20 '26 |
Sale |
1.73 |
17,250 |
29,896 |
105,983 |
| HARRY KOVELMAN | Officer |
Aug 20 '26 |
Proposed Sale |
1.73 |
17,500 |
30,329 |
0 |
| David Henry | Officer |
Jul 13 '26 |
Proposed Sale |
1.09 |
5,166 |
5,631 |
0 |
| Micah Mitchell | Officer |
Jun 12 '26 |
Proposed Sale |
1.20 |
9,061 |
10,873 |
0 |
| Harry Kovelman | Officer |
Jun 12 '26 |
Proposed Sale |
1.20 |
10,442 |
12,530 |
0 |
| Micah Mitchell | Officer |
Jun 08 '26 |
Proposed Sale |
1.33 |
6,529 |
8,684 |
0 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):